JPS63150209A - 皮膚化粧料 - Google Patents
皮膚化粧料Info
- Publication number
- JPS63150209A JPS63150209A JP29816086A JP29816086A JPS63150209A JP S63150209 A JPS63150209 A JP S63150209A JP 29816086 A JP29816086 A JP 29816086A JP 29816086 A JP29816086 A JP 29816086A JP S63150209 A JPS63150209 A JP S63150209A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- molecular weight
- aminobutyric acid
- effect
- sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 15
- 230000002378 acidificating effect Effects 0.000 claims abstract description 12
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 11
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920001287 Chondroitin sulfate Polymers 0.000 claims abstract description 10
- 229940059329 chondroitin sulfate Drugs 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 8
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 8
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 8
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920000045 Dermatan sulfate Polymers 0.000 claims abstract description 5
- 229920002971 Heparan sulfate Polymers 0.000 claims abstract description 5
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims abstract description 5
- 229940051593 dermatan sulfate Drugs 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 abstract description 30
- 230000007306 turnover Effects 0.000 abstract description 10
- 239000006210 lotion Substances 0.000 abstract description 9
- 230000032683 aging Effects 0.000 abstract description 8
- 239000002884 skin cream Substances 0.000 abstract description 6
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 76
- 238000012360 testing method Methods 0.000 description 21
- 210000004927 skin cell Anatomy 0.000 description 16
- 239000000126 substance Substances 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229940124277 aminobutyric acid Drugs 0.000 description 8
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 230000003712 anti-aging effect Effects 0.000 description 7
- -1 hyaluronic acid thorium salt Chemical class 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 102000011782 Keratins Human genes 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- AOKCDAVWJLOAHG-UHFFFAOYSA-N 4-(methylamino)butyric acid Chemical compound C[NH2+]CCCC([O-])=O AOKCDAVWJLOAHG-UHFFFAOYSA-N 0.000 description 3
- 230000020411 cell activation Effects 0.000 description 3
- 210000001339 epidermal cell Anatomy 0.000 description 3
- 238000004299 exfoliation Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 2
- 239000004808 2-ethylhexylester Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 210000000270 basal cell Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 210000000736 corneocyte Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- TUAXNBXNWXXFJC-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;sulfuric acid Chemical compound OS(O)(=O)=O.OC(=O)[C@@H](N)CCCNC(N)=N TUAXNBXNWXXFJC-WCCKRBBISA-N 0.000 description 1
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
- 108700016947 Bos taurus structural-GP Proteins 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 150000008535 L-arginines Chemical class 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940006423 chondroitin sulfate sodium Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 210000004565 granule cell Anatomy 0.000 description 1
- 229940014041 hyaluronate Drugs 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29816086A JPS63150209A (ja) | 1986-12-15 | 1986-12-15 | 皮膚化粧料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP29816086A JPS63150209A (ja) | 1986-12-15 | 1986-12-15 | 皮膚化粧料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63150209A true JPS63150209A (ja) | 1988-06-22 |
| JPH0465047B2 JPH0465047B2 (enrdf_load_stackoverflow) | 1992-10-16 |
Family
ID=17855973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP29816086A Granted JPS63150209A (ja) | 1986-12-15 | 1986-12-15 | 皮膚化粧料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63150209A (enrdf_load_stackoverflow) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0733635A (ja) * | 1993-07-21 | 1995-02-03 | Kao Corp | 皮膚外用剤 |
| JPH07242530A (ja) * | 1994-03-03 | 1995-09-19 | Kanebo Ltd | 皮膚化粧料 |
| WO1998019663A1 (en) * | 1996-11-04 | 1998-05-14 | Apr Applied Pharma Research S.A. | Compositions for topical use containing polysaccharide sulphates |
| FR2767692A1 (fr) * | 1997-09-01 | 1999-03-05 | Oreal | Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore ou potassique dans le traitement des peaux sensibles |
| WO2006101030A1 (ja) * | 2005-03-22 | 2006-09-28 | Q.P. Corporation | 低分子ヒアルロン酸および／またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
| WO2007099830A1 (ja) * | 2006-02-24 | 2007-09-07 | Q.P. Corporation | 新規な低分子ヒアルロン酸および／またはその塩、ならびにこれを用いた化粧料、医薬組成物および食品組成物 |
| JP2010511021A (ja) * | 2006-11-30 | 2010-04-08 | コーエン，マルセル | 色素脱失剤としてのガンマアミノ酪酸の利用 |
| US20110288047A1 (en) * | 2008-11-20 | 2011-11-24 | Laboratori Derivati Organici Spa | Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations |
| KR20180113935A (ko) * | 2017-04-07 | 2018-10-17 | (주)유레 | 저분자량 히알루론산의 제조 방법 |
| IT202000008299A1 (it) * | 2020-04-17 | 2021-10-17 | Glycores 2000 Srl | Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5457675B2 (ja) * | 2006-10-17 | 2014-04-02 | 株式会社ヒアルロン酸研究所 | アトピー性皮膚炎の治療薬又は予防薬 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5452733A (en) * | 1977-10-04 | 1979-04-25 | Pola Kasei Kogyo Kk | Skin cosmetics |
| JPS5826726A (ja) * | 1981-08-05 | 1983-02-17 | Hitachi Plant Eng & Constr Co Ltd | 粉体供給装置 |
| JPS60184005A (ja) * | 1984-03-02 | 1985-09-19 | Kanebo Ltd | 皮膚老化防止用化粧料 |
-
1986
- 1986-12-15 JP JP29816086A patent/JPS63150209A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5452733A (en) * | 1977-10-04 | 1979-04-25 | Pola Kasei Kogyo Kk | Skin cosmetics |
| JPS5826726A (ja) * | 1981-08-05 | 1983-02-17 | Hitachi Plant Eng & Constr Co Ltd | 粉体供給装置 |
| JPS60184005A (ja) * | 1984-03-02 | 1985-09-19 | Kanebo Ltd | 皮膚老化防止用化粧料 |
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0733635A (ja) * | 1993-07-21 | 1995-02-03 | Kao Corp | 皮膚外用剤 |
| JPH07242530A (ja) * | 1994-03-03 | 1995-09-19 | Kanebo Ltd | 皮膚化粧料 |
| WO1998019663A1 (en) * | 1996-11-04 | 1998-05-14 | Apr Applied Pharma Research S.A. | Compositions for topical use containing polysaccharide sulphates |
| FR2767692A1 (fr) * | 1997-09-01 | 1999-03-05 | Oreal | Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore ou potassique dans le traitement des peaux sensibles |
| WO1999011238A1 (fr) * | 1997-09-01 | 1999-03-11 | L'oreal | Utilisation d'une substance agoniste d'un recepteur associe a un canal chlore ou potassique dans le traitement des peaux sensibles |
| US6572848B1 (en) | 1997-09-01 | 2003-06-03 | Societe L'oreal S.A. | Use of a substance agonist of a receptor associated with a chlorine or potassium canal for treating sensitive skins |
| WO2006101030A1 (ja) * | 2005-03-22 | 2006-09-28 | Q.P. Corporation | 低分子ヒアルロン酸および／またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
| JP2006265287A (ja) * | 2005-03-22 | 2006-10-05 | Q P Corp | 低分子ヒアルロン酸および／またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
| US8933054B2 (en) | 2005-03-22 | 2015-01-13 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, method for producing same, and cosmetic preparation and food composition containing same |
| WO2007099830A1 (ja) * | 2006-02-24 | 2007-09-07 | Q.P. Corporation | 新規な低分子ヒアルロン酸および／またはその塩、ならびにこれを用いた化粧料、医薬組成物および食品組成物 |
| JP5289936B2 (ja) * | 2006-02-24 | 2013-09-11 | キユーピー株式会社 | 新規な低分子ヒアルロン酸および／またはその塩、ならびにこれを用いた化粧料、医薬組成物および食品組成物 |
| US8367818B2 (en) | 2006-02-24 | 2013-02-05 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same |
| JP2010511021A (ja) * | 2006-11-30 | 2010-04-08 | コーエン，マルセル | 色素脱失剤としてのガンマアミノ酪酸の利用 |
| US20110288047A1 (en) * | 2008-11-20 | 2011-11-24 | Laboratori Derivati Organici Spa | Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations |
| JP2012509289A (ja) * | 2008-11-20 | 2012-04-19 | ラボラトリ・デリバティ・オルガニシ・エス・ピー・エイ | ヘパラン硫酸の精製方法並びに美容用及び皮膚用調製物中におけるその使用 |
| US9440099B2 (en) * | 2008-11-20 | 2016-09-13 | Laboratori Derivati Organici Spa | Process for the purification of heparan sulfate and use thereof in cosmetological and dermatological preparations |
| JP2017043638A (ja) * | 2008-11-20 | 2017-03-02 | ラボラトリ・デリバティ・オルガニシ・エス・ピー・エイ | ヘパラン硫酸の精製方法並びに美容用及び皮膚用調製物中におけるその使用 |
| KR20180113935A (ko) * | 2017-04-07 | 2018-10-17 | (주)유레 | 저분자량 히알루론산의 제조 방법 |
| CN110431155A (zh) * | 2017-04-07 | 2019-11-08 | 优瑞有限公司 | 低分子量透明质酸的制备方法 |
| EP3608343A4 (en) * | 2017-04-07 | 2020-11-04 | Youreh Co., Ltd. | PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT HYALURONIC ACID |
| IT202000008299A1 (it) * | 2020-04-17 | 2021-10-17 | Glycores 2000 Srl | Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare |
| WO2021209974A1 (en) * | 2020-04-17 | 2021-10-21 | Glycores 2000 S.R.L. | Process for the preparation of low molecular weight linear hyaluronic acid and hyaluronic acid so obtained |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0465047B2 (enrdf_load_stackoverflow) | 1992-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110664644B (zh) | 一种含叶酸的护肤组合物、精华及其制备方法 | |
| JPH10182412A (ja) | 外用剤 | |
| KR20190010795A (ko) | 신규한 하이알폴 매트릭스 혼합물이 함유된 피부 보습 강화, 주름 개선 및 미백용 화장료 조성물 및 그 제조방법 | |
| JPS63150209A (ja) | 皮膚化粧料 | |
| CN111012699A (zh) | 一种含褐藻糖海带提取物的抗氧化控油乳液 | |
| JP3922311B2 (ja) | 皮膚老化防止化粧料 | |
| KR20050103903A (ko) | 노화되거나 환경에 손상된 피부를 치료하기 위한 국소적조성물 및 치료 방법 | |
| JPH06104620B2 (ja) | 皮膚化粧料 | |
| JP2511820B2 (ja) | 皮膚化粧料 | |
| CN107496191A (zh) | 一种睡莲植物多肽补水保湿面膜精华液及其制备方法 | |
| JP3507635B2 (ja) | 外用に適する組成物 | |
| JPS63150210A (ja) | 養毛化粧料 | |
| JP2553474B2 (ja) | 皮膚化粧料 | |
| JPS6281307A (ja) | 皮膚化粧料 | |
| JP2511817B2 (ja) | 皮膚化粧料 | |
| JP2004075635A (ja) | 保湿剤及び皮膚外用剤 | |
| JPS62138411A (ja) | 皮膚老化防止用化粧料 | |
| CN113499277A (zh) | 一种抗衰组合物及其制备方法与应用 | |
| CN110464666A (zh) | 眼唇霜及其制备方法 | |
| JPS62148414A (ja) | 皮膚化粧料 | |
| JPS63139104A (ja) | 皮膚化粧料 | |
| JPS6368512A (ja) | 皮膚外用剤 | |
| JPS62153206A (ja) | 皮膚化粧料 | |
| JP3001942B2 (ja) | 皮膚化粧料 | |
| JPS62249912A (ja) | 皮膚化粧料 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |